Cognitive Functioning
14
5
5
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Selenium Intervention Registry Randomized Trial in Heart Failure
Turkish Validation of the Parkinson Disease Cognitive Functional Rating Scale
Dual Orexin Antagonism and Emotion and Affective Processing Study
Group Recreation to Enhance Function Aging
Nature Exposure Through Virtual Reality (NET-VR) in Older Adults
This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65.
Comparison of Vestibulo-Ocular Reflex and Cognitive Functions in E-Athletes and Non-Athletes
The Effect of General Anesthesia with Remimazolam and Propofol on Rhythmic State and Cognitive Function
Expected and Actual Preterm-Birth and Parental Distress: Impact on Children's Mental Health
Assessing Modified CBTi in Adults with Insomnia Disorder
Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia
Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository
WILD 5 Wellness, A 30-Day Intervention
Efficacy Study of AlphaBRAIN Administered Orally